Alumis, Kaken Pharmaceutical Enter Collaboration, Licensing Deal for Dermatology Drug

In This Article:

Alumis (ALMS) and Kaken Pharmaceutical have struck a collaboration and licensing agreement to develo

Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.